National Bank of Canada’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
National Bank of Canada's GILD Position: Q1 2026 in Review
National Bank of Canada reduced its Gilead Sciences (GILD) stake by 15% in Q1 2026, selling an estimated $40M and leaving 1,614,500 shares worth $225M. The position accounts for 0.2% of the portfolio, ranked #91.
National Bank of Canada first reported a position in GILD in Q4 2021 and has held it in 18 quarters since. The position peaked at $233M in Q4 2025. 2,313 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- National Bank of Canada held 1,614,500 shares of Gilead Sciences worth $225M as of Q1 2026.
- National Bank of Canada sold 285,561 Gilead Sciences shares in Q1 2026, an estimated $40M.
- Gilead Sciences made up 0.2% of National Bank of Canada's portfolio in Q1 2026, its #91 holding.
- National Bank of Canada first reported a position in Gilead Sciences in Q4 2021 and has held it in 18 quarters since.
- National Bank of Canada's Gilead Sciences position peaked at $233M in Q4 2025.
- 2,313 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.